BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36656526)

  • 1. Refolding of Proteins Expressed as Inclusion Bodies in E. coli.
    Sharma R; Anupa A; Rathore AS
    Methods Mol Biol; 2023; 2617():201-208. PubMed ID: 36656526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Solubilization and Refolding Buffers.
    Roufarshbaf M; Akbari V
    Methods Mol Biol; 2023; 2617():155-164. PubMed ID: 36656522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli.
    Noguchi T; Nishida Y; Takizawa K; Cui Y; Tsutsumi K; Hamada T; Nishi Y
    J Immunol Methods; 2017 Mar; 442():1-11. PubMed ID: 27939301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies.
    Yamaguchi H; Miyazaki M
    Biomolecules; 2014 Feb; 4(1):235-51. PubMed ID: 24970214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical characterization of in vitro refolding in the quality by design paradigm: Refolding of recombinant human granulocyte colony stimulating factor.
    Pathak M; Dixit S; Muthukumar S; Rathore AS
    J Pharm Biomed Anal; 2016 Jul; 126():124-31. PubMed ID: 27206104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Method for Inclusion Bodies Production via E. coli Host System: rGCSF as Model Biotherapeutic Protein.
    Rani AK; Naira VR; Rathore AS
    Methods Mol Biol; 2023; 2617():249-256. PubMed ID: 36656530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and purification of recombinant human granulocyte colony-stimulating factor in fed-batch culture of Escherichia coli.
    Kim CK; Choi JH; Lee SB; Lee SM; Oh JW
    Appl Biochem Biotechnol; 2014 Mar; 172(5):2425-35. PubMed ID: 24390866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient process development of recombinant human granulocyte colony-stimulating factor (rh-GCSF) production in Escherichia coli.
    Babaeipour V; Khanchezar S; Mofid MR; Pesaran Hagi Abbas M
    Iran Biomed J; 2015; 19(2):102-10. PubMed ID: 25864815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.
    Bajaj P; Tripathy RK; Aggarwal G; Pande AH
    Protein Expr Purif; 2015 Nov; 115():95-101. PubMed ID: 26003526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process.
    Sarker A; Rathore AS; Gupta RD
    Microb Cell Fact; 2019 Jan; 18(1):5. PubMed ID: 30642336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization and Refolding of Inclusion Body Proteins.
    Singhvi P; Panda AK
    Methods Mol Biol; 2022; 2406():371-387. PubMed ID: 35089569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unit Operation-Spanning Investigation of the Redox System.
    Ebner J; Humer D; Sedlmayr V
    Methods Mol Biol; 2023; 2617():165-176. PubMed ID: 36656523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of recombinant human G-CSF from non-classical inclusion bodies in Escherichia coli.
    Trinh NTM; Thuoc TL; Thao DTP
    Braz J Microbiol; 2021 Jun; 52(2):541-546. PubMed ID: 33483893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
    Panda AK
    Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma.
    Krachmarova E; Ivanov I; Nacheva G
    Microb Cell Fact; 2020 Jul; 19(1):139. PubMed ID: 32652996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, Solubilization, Refolding and Final Purification of Recombinant Proteins as Expressed in the form of "Classical Inclusion Bodies" in
    Hashemzadeh MS; Mohammadi M; Ghaleh HEG; Sharti M; Choopani A; Panda AK
    Protein Pept Lett; 2021; 28(2):122-130. PubMed ID: 32729411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human growth hormone inclusion bodies present native-like secondary and tertiary structures which can be preserved by mild solubilization for refolding.
    Chura-Chambi RM; Farah CS; Morganti L
    Microb Cell Fact; 2022 Aug; 21(1):164. PubMed ID: 35978337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization and refolding of bacterial inclusion body proteins.
    Singh SM; Panda AK
    J Biosci Bioeng; 2005 Apr; 99(4):303-10. PubMed ID: 16233795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MB109 as bioactive human bone morphogenetic protein-9 refolded and purified from E. coli inclusion bodies.
    Kuo MM; Nguyen PH; Jeon YH; Kim S; Yoon SM; Choe S
    Microb Cell Fact; 2014 Feb; 13(1):29. PubMed ID: 24559319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New properties of inclusion bodies with implications for biotechnology.
    Peternel S; Jevsevar S; Bele M; Gaberc-Porekar V; Menart V
    Biotechnol Appl Biochem; 2008 Apr; 49(Pt 4):239-46. PubMed ID: 17708747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.